Browse by Uncontrolled Keywords

Export as [feed] Atom [feed] RSS
Group by: Year | Authors/Creators | Item Type | Full Text
Jump to: K | M | N | P | S
Number of items: 5.

K

Kayser, O; Olbrich, C; Croft, SL; Kiderlen, AF; (2003) Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs. Parasitology research, 90. S63-S70. ISSN 0932-0113 DOI: https://doi.org/10.1007/s00436-002-0769-2 Full text not available from this repository.

M

Murray, HW; Berman, JD; Davies, CR; Saravia, NG; (2005) Advances in leishmaniasis. Lancet, 366 (9496). pp. 1561-1577. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(05)67629-5 Full text not available from this repository.

N

Nan, A; Nanayakkara, NPD; Walker, LA; Yardley, V; Croft, SL; Ghandehari, H; (2001) N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers for targeted delivery of 8-aminoquinoline antileishmanial drugs. Journal of controlled release, 77 (3). pp. 233-43. ISSN 0168-3659 https://researchonline.lshtm.ac.uk/id/eprint/16572 Full text not available from this repository.

P

Patel, TA; Lockwood, DN; (2009) Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases. Tropical medicine & international health, 14 (9). pp. 1064-1070. ISSN 1360-2276 DOI: https://doi.org/10.1111/j.1365-3156.2009.02329.x Full text not available from this repository.

S

Sindermann, H; Croft, SL; Engel, KR; Bommer, W; Eibl, HJ; Unger, C; Engel, J; (2004) Miltefosine (Impavido): the first oral treatment against leishmaniasis. Medical microbiology and immunology. p. 173. ISSN 0300-8584 DOI: https://doi.org/10.1007/s00430-003-0201-2 Full text not available from this repository.

This list was generated on Thu Jul 25 15:59:26 2019 BST.